Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7686546rdf:typepubmed:Citationlld:pubmed
pubmed-article:7686546lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:7686546lifeskim:mentionsumls-concept:C0062823lld:lifeskim
pubmed-article:7686546lifeskim:mentionsumls-concept:C0204514lld:lifeskim
pubmed-article:7686546pubmed:issue3lld:pubmed
pubmed-article:7686546pubmed:dateCreated1993-7-30lld:pubmed
pubmed-article:7686546pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:abstractTextTwo genes encoding HLA-B60 or HLA-B61 were cloned from Japanese and the exons of their genes were sequenced. One silent mutation was observed at the exon 1 between HLA-B60 (B*40012) and B*40011. Seven nucleotide substitutions were seen at the exon 3 between HLA-B61 (B*4006) and B*4002. Three substitutions at codon 95, CTC in B*4002 to TGG in B*4006, changed Leu in B*4002 to Trp in B*4006, while two substitutions at codon 97, AGC in B*4002 and ACG in B*4006, changed Ser in B*4002 to Thr in B*4006. Since B*4002 shares the epitope of alloantibodies specific for HLA-B61, two HLA-B61 subtypes are discriminated by two amino acid substitutions at residues 95 and 97. B*40012 and B*4006 differ by four amino acid substitutions on the beta sheet and five amino acid substitutions on the alpha 2 helix. Since the residues at the beta sheet seem hardly to affect the binding of alloantibody, it is suspected that the residues on the alpha 2 helix provide epitopes for alloantibodies that discriminate allospecificity between HLA-B60 and HLA-B61.lld:pubmed
pubmed-article:7686546pubmed:languageenglld:pubmed
pubmed-article:7686546pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:citationSubsetIMlld:pubmed
pubmed-article:7686546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686546pubmed:statusMEDLINElld:pubmed
pubmed-article:7686546pubmed:monthMarlld:pubmed
pubmed-article:7686546pubmed:issn0198-8859lld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KatoNNlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KanoKKlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:BOEHMH OHOlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:TakiguchiMMlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KohsakaTTlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KarakiSSlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KawaguchiGGlld:pubmed
pubmed-article:7686546pubmed:authorpubmed-author:KashiwaseKKlld:pubmed
pubmed-article:7686546pubmed:issnTypePrintlld:pubmed
pubmed-article:7686546pubmed:volume36lld:pubmed
pubmed-article:7686546pubmed:geneSymbolHLA-Blld:pubmed
pubmed-article:7686546pubmed:geneSymbolHLA-B*40012lld:pubmed
pubmed-article:7686546pubmed:geneSymbolHLA-B*4006lld:pubmed
pubmed-article:7686546pubmed:ownerNLMlld:pubmed
pubmed-article:7686546pubmed:authorsCompleteYlld:pubmed
pubmed-article:7686546pubmed:pagination193-8lld:pubmed
pubmed-article:7686546pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:meshHeadingpubmed-meshheading:7686546-...lld:pubmed
pubmed-article:7686546pubmed:year1993lld:pubmed
pubmed-article:7686546pubmed:articleTitleStructural analysis of HLA-B40 epitopes.lld:pubmed
pubmed-article:7686546pubmed:affiliationDepartment of Tumor Biology and Immunology, University of Tokyo, Japan.lld:pubmed
pubmed-article:7686546pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7686546pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7686546pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3106entrezgene:pubmedpubmed-article:7686546lld:entrezgene